SEEN, the award-winning haircare brand developed by Harvard-trained dermatologist Dr. Iris Rubin, has successfully secured $9 million in a Series A funding round. This latest investment will fuel SEEN’s growth as a leading science-backed and clinically-proven beauty brand, strategically positioned at the intersection of billion-dollar markets, including haircare, sensitive skin, acne, eczema, dry scalp, and hair thinning.

The fully subscribed funding round saw strong participation from both existing and new strategic investors. Notable participants include Mitch Rales, Co-Founder of Danaher Corporation; Somerville SPV, led by acclaimed investor Feroz Dewan; Sator Grove Holdings, a permanent capital investor; and George Mrkonic, Board Director of Ulta Beauty, Inc. SEEN also received early funding from prominent Harvard dermatologists and scientists, including Dr. Rox Anderson of Harvard/Massachusetts General Hospital.

“This marks another transformative milestone for SEEN,” said Dr. Iris Rubin, Co-Founder of SEEN. “A majority of adults in the U.S. have self-described sensitive skin, and over 100 million people in the U.S. suffer from acne, eczema, dry scalp, and hair shedding, conditions often exacerbated by irritating, allergenic, and pore-clogging ingredients in hair products. Our mission is to help people feel confident being seen by offering salon-quality hair formulations that are clinically proven to be skin-friendly.”

Popular

MeWe Launches Series B Funding to Accelerate Web3 Integration for 20 Million Users

With the new Series A funding, SEEN plans to focus on innovation and scale its professional sampling to 10,000 dermatology practices by 2025. The brand also aims to expand its retail presence further. “We’ve had 100% compounded annual growth since our launch and consistently exceed Ulta’s sales projections for the brand,” said Greg Maged, Co-Founder of SEEN.

SEEN is at the forefront of the “skinification” of hair care, bridging the gap between luxury haircare and skincare. Dr. Rubin’s groundbreaking insight that hair products can clog pores and irritate the skin, causing acne and eczema, led to the brand’s creation. After years of struggling with breakouts, Dr. Rubin identified her haircare products as the culprit. Following four years of development, SEEN launched in 2019 with three core products and has since expanded into a comprehensive line of haircare and styling products.

Investor George Mrkonic, who currently serves on the Board of Ulta Beauty, Inc., expressed his enthusiasm for SEEN: “I am delighted to become an investor in SEEN and believe they are setting a new standard for performance hair care. SEEN is applying skin science to haircare, which is exactly the kind of category-defining innovation that gets Ulta excited.”

Mitch Rales, another key investor, added, “When we invest in a brand, we look for companies with large market potential, strong margins, and a platform that creates unique consumer benefits. We also want to invest in leadership that is smart, agile, and driven by a passion for excellence. SEEN embodies all these qualities.”

SEEN has been widely embraced by the dermatology community for its rigorous application of skin science to haircare. The brand’s Epidermal Rebalancing Technology uses efficacious, skin-friendly ingredients to create hair and body products that promote stronger, smoother, and healthier hair while also enhancing skin health. SEEN holds five patents, boasts over 7,000 5-star reviews, and has received more than a dozen beauty awards. The brand’s fragrance-free line has earned the National Eczema Association’s Seal of Acceptance.

SEEN products are available nationwide through HelloSeen.com, ULTA, Amazon, Dermstore, and SkinStore. With this latest funding round, SEEN is well-positioned to continue its mission of providing dermatology-backed haircare solutions that cater to the needs of sensitive skin while setting new industry standards.